Published in

Nature Research, Nature Communications, 1(7), 2016

DOI: 10.1038/ncomms11273

Links

Tools

Export citation

Search in Google Scholar

Clec4A4 is a regulatory receptor for dendritic cells that impairs inflammation and T-cell immunity

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

AbstractDendritic cells (DCs) comprise several subsets that are critically involved in the initiation and regulation of immunity. Clec4A4/DC immunoreceptor 2 (DCIR2) is a C-type lectin receptor (CLR) exclusively expressed on CD8α conventional DCs (cDCs). However, how Clec4A4 controls immune responses through regulation of the function of CD8α cDCs remains unclear. Here we show that Clec4A4 is a regulatory receptor for the activation of CD8α cDCs that impairs inflammation and T-cell immunity. Clec4a4−/−CD8α cDCs show enhanced cytokine production and T-cell priming following Toll-like receptor (TLR)-mediated activation. Furthermore, Clec4a4−/− mice exhibit TLR-mediated hyperinflammation. On antigenic immunization, Clec4a4−/− mice show not only augmented T-cell responses but also progressive autoimmune pathogenesis. Conversely, Clec4a4−/− mice exhibit resistance to microbial infection, accompanied by enhanced T-cell responses against microbes. Thus, our findings highlight roles of Clec4A4 in regulation of the function of CD8α cDCs for control of the magnitude and quality of immune response.